NIH announced four Phase 2 winners of the Neuromod Prize, a $9.8 million competition to accelerate the development of targeted neuromodulation therapies. The winning teams will each receive $1 million and an exclusive invitation to join Phase 3 of the competition. The Neuromod Prize is a SPARC (Stimulating Peripheral Activity to Relieve Conditions) initiative from NIH that is accelerating the development of targeted neuromodulation therapies. Learn more about the winning projects.